Halotestin (Fluoxymestrone)

Description

Description

Halotestin (Fluoxymestrone)

Maker: Hilma Biocare
Pack: 100 tablets/bottle (5mg/tab)
Drug class: androgen anabolic steroid
Common names: Android-F, Androxy, Halotestin, Ora-Testryl, Ultandren
Chemical structure: 9-alpha-fluoro-11-bta-hydroxy-17-alpha-methyl-4-androstne-3-one,17b-ol

Information

Fluoxymestrone is an anabolic androgenic steroid derived from testosterone or more specifically a structurally modified form of methyltestosterone. Halotestin is the testosterone hormone with an added methyl group at the 17th carbon position to allow for oral ingestion. It also has an added fluoro group at carbons 9 and 3 and a hydroxyl group at carbon 11. These modifications inhibit aromatization of the steroid and greatly increase its androgenic nature. The androgenic nature and activity of Halotestin will be far beyond methyltestostrone. By structural design, Halotestin has an anabolic rating of 1,900 and an androgenic rating of 850. All ratings are measured against pure testosterone, which has a rating of 100 in both categories. This means that Halotestin carries ratings that are almost beyond reason, but its anabolic rating is extremely deceiving. Although it carries a massive anabolic rating, its anabolic translation in human beings appears to be close to zero. This steroid simply does not result in a noticeable anabolic effect and will work primarily through androgenic activity.

Profile Halotestin

• Androgen index (850)
• Anabolic Index (1,900)
• Estrogen Level None
• Low progestogen activity
• Liver toxicity – Very high
• Water retention – None

Effects

• Improves strength
• lean muscle mass
• fat burning
• muscle definition

Dose range and duration of use

• Common cycle length is 2 4 weeks
• Intake range: 10-20mg/daily
• Women: Not recommended
• Half-life: 9.2 hours (active life 6-8 hours)
• Detection time: 2 months

Side effects

Halotestin is an androgen. Androgenic side effects are common, such as oily skin, acne, growth of facial and body hair. Anabolic/androgenic steroids can also make hair loss worse in men. May increase aggression. Women are further warned of the potential virilizing effects of anabolic/androgenic steroids. These can include a deepening of the voice, menstrual irregularities, changes in skin texture, growth of facial hair and enlargement of the clitoris.
Anabolic/androgenic steroids may have deleterious effects on serum cholesterol. This includes a tendency to reduce HDL cholesterol values ​​and increase LDL cholesterol values, which can alter the HDL to LDL balance, which can increase the risk of arteriosclerosis. The relative impact of an anabolic/androgenic steroid on serum lipids depends on dose, route of administration (oral vs injectable), type of steroid (flavourable or non-flavourable), and level of resistance to hepatic metabolism. Halotestin has a significant effect on hepatic management of cholesterol due to its structural resistance to liver breakdown and the route of administration. Halotestin can also affect blood pressure and triglycerides, reduce endothelial relaxation and promote left ventricular hypertrophy, potentially increasing the risk of cardiovascular disease and myocardial infarction.To help reduce cardiovascular strain, it is advisable to maintain an active cardiovascular exercise program and to minimize the intake of saturated fat, cholesterol and simple carbohydrates at all times during active administration of ASA. Fish oil supplementation (4 grams per day) and a natural cholesterol/antioxidant formula such as Lipid Stabil or a product with comparable ingredients is also recommended.
All anabolic/androgenic steroids, when taken in sufficient doses to promote muscle gain, should suppress natural testosterone production. Without PTC intervention, testosterone levels should return to normal within 1-4 months of drug withdrawal. Note that prolonged hypogonadotrophic hypogonadism may develop as a result of steroid abuse, requiring medical intervention.
Studies administering 10mg, 20mg, or 30mg of Halotestin to nine healthy male subjects for up to 12 weeks have demonstrated strong suppression of natural testosterone levels, with inconsistent effects on gonadotropin levels. Although not fully understood, fluoxymestrone is proposed to have a direct suppressive effect on testicular estrogen syndrome which is not mediated by suppressive gonadotropins.

Storage room

Store at controlled room temperature of 20 to 25 C (68 to 77 F)

After cycle therapy

Post cycle therapy starts after 24 hours, after the last administration. Use gonadotropin with Novaldex to stimulate the production of your own testosterone.